DiA Imaging Analysis

Company Overview

Snapshot

Founded in October 2009 by Arnon Toussia Cohen, Noah Liel - Cohen, Hila Goldman Aslan, and Hugo Guterman, DiA Imaging Analysis operates with 11–50 employees. The company raised $22.46 million across 6 funding rounds from 14 investors. DiA Imaging Analysis was acquired by Philips in May 2023.

Business overview

DiA Imaging Analysis provides AI-powered ultrasound analysis software designed to address challenges in capturing and analyzing ultrasound images. Its technology leverages advanced pattern recognition, deep learning, and machine learning algorithms to automatically imitate human eye detection of image borders and motion. The company's flagship product, LVivo Seamless, is an AI-based solution that preselects and instantly analyzes optimal apical cardiac ultrasound views, generating measurements for Strain, EF, and Right Ventricle Size and Function. This software reduces variability associated with manual analysis, serving the healthcare industry, particularly hospitals and clinics, within the digital healthcare and medical decision support sectors.

Strategic signal

DiA Imaging Analysis was acquired by Philips in May 2023. This acquisition by a major multinational corporation like Philips validates DiA's AI-driven ultrasound technology and its potential for broader integration into healthcare systems, signaling strong market demand for AI-enhanced diagnostic tools and a strategic exit for investors.

Company Intelligence Q&A

When was DiA Imaging Analysis acquired?

DiA Imaging Analysis was acquired by Philips in May 2023.

Which company partnered with DiA Imaging Analysis to enhance ultrasound with AI-based image quantification?

In March 2021, DiA Imaging Analysis partnered with Philips to enhance ultrasound with AI-based image quantification.

Did DiA Imaging Analysis receive any grants?

In May 2020, DiA Imaging Analysis received a grant from the Israel Innovation Authority to accelerate global access to its AI ultrasound solutions in the fight against COVID-19.

What was a key product development for DiA Imaging Analysis?

In February 2023, DiA Imaging Analysis secured FDA clearance for new AI-powered software designed to assist ultrasound users in capturing high-quality images.